BioSpace News Archive

Protagonist Therapeutics, Inc. (Nasdaq: PTGX) (“Protagonist” or “the Company”) today announced that Dinesh V. Patel , Ph.D., President and Chief Executive Officer and Scott Plevy , M.D., Executive Vice President and Therapeutic Head, Gastroenterology will participate in a fireside chat at the upcoming Jefferies Next Generation IB Therapeutics Summit taking place virtually on October 19, 2021.

AavantiBio today announced it is partnering with the University of Florida to research and develop next generation gene therapy capsids with the goal of creating safer, more effective, and tissue specific gene therapies.

Deciphera Announces Approval of QINLOCK ® in Switzerland for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor

Delphinus Medical Technologies, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of its SoftVue™ 3D Whole Breast Ultrasound Tomography System (SoftVue™) for use as an adjunct to digital mammography in the screening of asymptomatic women with dense breast tissue.

CureVac N.V. today announced the strategic decision to focus its COVID-19 vaccine development towards the development of second-generation mRNA vaccine candidates in collaboration with GSK and to withdraw its first-generation COVID-19 vaccine candidate, CVnCoV, from the current approval process with the European Medicines Agency (EMA).

Windtree Therapeutics, Inc. today announced the results of a US physician survey and an assessment of worldwide total market value for cardiogenic shock.

Spark Therapeutics and CombiGene AB (‘CombiGene’) today announced the signing of an exclusive collaboration and licensing agreement for CombiGene’s CG01 project, an investigational gene therapy which aims to treat drug resistant focal epilepsy.

BridgeBio Pharma, Inc. is announcing meaningful progress in its KRAS cancer portfolio, new programs in gene therapy, and advancements in cardiorenal and early-stage Mendelian programs at its second annual R&D Day today.

Integral Molecular, a founding member of Philadelphia’s biotech community, celebrates its 20th anniversary as a leader in antibody discovery and virology.

Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) The extra general meeting was held today on 12 October 2021 and the following resolutions were passed by the meeting.